SUTENT is used to treat GIST (gastrointestinal stromal tumor). This is a rare cancer of the stomach, bowel, or esophagus. SUTENT is used when the medicine Gleevec® (imatinib mesylate) did not stop the cancer from growing or when you cannot take Gleevec.
Gleevec is a registered trademark of Novartis AG.

SUTENT is a medicine that treats cancer. It comes in 12.5-mg, 25-mg, and 50-mg capsules.
You take SUTENT once per day by mouth. Do not open the capsules.
SUTENT has been approved by the FDA to treat patients with gastrointestinal stromal
tumor (GIST). SUTENT is used when the medicine Gleevec® (imatinib mesylate) does
not stop the cancer from growing or when you cannot take Gleevec.
SUTENT is available by prescription only. Your doctor has prescribed SUTENT because
he or she believes it is the most appropriate treatment for you. SUTENT may not
be appropriate for all GIST patients and has not been studied in children. For many
patients, SUTENT may slow or stop the growth of cancer and may help to shrink tumors.
SUTENT may not work the same in every person.